Imaging Characteristics of Breast Lymphoma; a Case Series by Rehman, Sara et al.
Journal Of Cancer & Allied Specialties 1
Original ArticleJ Cancer Allied Spec 2020;6(1):1
Sara Rehman, Muhammad Atif Naveed, Javaria Aleem
Department of Radiology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, 
Pakistan
Received: 03 November 2019/Accepted: 27 December 2019
Abstract
Introduction: Breast involvement by lymphoma is rare. It can occur 
as a primary breast tumour or as an extranodal manifestation of the 
systemic disease. The imaging features of breast lymphoma (BL) are 
not characteristic. Biopsy is necessary for diagnosis due to non-specific 
imaging features. Materials and Methods: A  retrospective electronic 
medical chart review was conducted of patients diagnosed with lymphoma 
of breast that underwent diagnostic radiological procedures (including 
mammography, ultrasound breast, computed tomography (CT) scan and 
positron emission tomography (PET/CT) scan from 1 July 2018 to 31 March 
2019 at Shaukat Khanum Memorial Cancer Hospital and Research Centre, 
Pakistan. Results: Four patients were identified. On mammogram, the most 
common finding consisted of the presence of high-density masses with 
circumscribed or indistinct margins. On ultrasound, hypoechoic masses 
and indistinct diffuse infiltrative patterns were observed. PET/CT and CT 
were helpful in detecting extramammary sites of disease and for classifying 
the disease into primary or secondary BL. Conclusion: The early diagnosis 
of the BL is important. The radiologists should include lymphoma in the 
differential diagnosis when there is the absence of microcalcifications or 
spiculated margins on mammography and ultrasound.
Key words: Breast lymphoma, case series, mammogram, positron 
emission tomography/computed tomography imaging, ultrasound
Introduction
Breast is an uncommon site for haematological 
malignancies. Lymphoma is the most common 
haematological malignancy affecting the breast. The 
incidence of breast lymphoma (BL) is approximately 
0.04%–0.70% of all breast malignancies.[1] Secondary 
forms of the disease are more common than primary 
disease. Nonetheless, primary BL (PBL) accounts for 
0.05%–0.53% of all breast region cancers.[2,3]
BL can present with several non-specific symptoms 
clinically, such as painless or palpable breast 
mass(es). Occasionally, nipple retraction or 
discharge and skin changes may also occur, which 
may mimic primary breast carcinoma.[2,4] PBL 
usually presents early as palpable breast mass and 
as a solitary mass on imaging.[2] In comparison, 
secondary BL (SBL) affects older age group with 
usually a non-specific occult clinical presentation, 
multiplicity on imaging and simultaneous disease 
in the breast and other visceral organs.[3]
There is only handful of studies which have focused 
on the radiological features of BL, and they show 
that there are no pathognomonic features of BL.[3,4] 
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To the best of our knowledge, no investigation has 
been carried out to assess the imaging features 
of BL in our population. The aim of the present 
investigation was to evaluate the radiological 
features of BL in this region.
Materials and Methods
A retrospective electronic medical chart review 
was conducted of patients that were diagnosed 
with BL and had underwent diagnostic radiological 
procedures including mammography, ultrasound 
breast, computed tomography (CT) scan or positron 
emission tomography (PET/CT) from 1 July 2018 
to 31  March 2019 at Shaukat Khanum Memorial 
Cancer Hospital and Research Centre, Pakistan. 
Breast cancers of other aetiology or BL patient 
without any diagnostic radiological investigation 
were excluded from the study. This study was 
approved by the Institutional Review Board of 
Shaukat Khanum Memorial Cancer Hospital and 
Research Centre (04-07-19-01).
The investigators deidentified the medical data 
for all participants. Information regarding the 
participants’ demographic data, age, medical 
history, diagnosis, pathological reports and 
radiological studies were extracted.
All participants underwent a combination of 
imaging modalities. These consisted of ultrasound 
breast, mammograms, CT scan of chest, abdomen 
and pelvis with contrast and PET/CT. The decision 
on the type of imaging was based on the clinical 
presentation, available resources and results of prior 
investigations. Ultrasound imaging was performed 
for breasts using 7.5 MHz linear array transducer 
Toshiba Aplio XG. Breast mammograms were 
performed bilaterally on dedicated mammographic 
equipment; Senographe Essential (GE), which was 
using to acquire standard mediolateral oblique 
and craniocaudal views. Baseline CT scan of chest, 
abdomen and pelvis with intravenous contrast was 
carried on Prime SP Aquilion scanner (160 slice), 
after administration of 1.5–1.67 ml/kg of iodinated 
intravenous contrast medium at a rate of 1.5–2 ml/s 
by a Medrad Salient injector with a scan delay 
of 70 s after onset of injection. Typical imaging 
parameters were 120 kVp, 150 mAs and 5  mm 
slice thickness with a pitch of 1.2. PET/CT was as 
performed by administering 5 MBq/kg body weight 
(F-18)-fluorodeoxyglucose intravenously. Imaging 
was performed on an integrated 16 slice Gemini EF 
PET/CT scanner (Philips), with scanning from head 
to thigh. The subsequent CT scan was performed 
with intravenous contrast material, using parameters 
and equipment as described before.
The diagnosis of BL was made based on the 
histopathological findings of ultrasound-guided 
biopsy. Classification into primary and secondary 
lymphoma was done on the basis of radiological 
findings on CT scan or PET/CT as per Wiseman 
and Lao criteria for PBL [Table  1].[5] All patients 
were discussed in multidisciplinary team (MDT) 
meeting and underwent follow-up evaluation. The 
response of treatment was assessed according to 




A 60-year-old woman presented with the history 
of the left breast lump for 1 month. There was no 
history of fever, night sweats or chills. On physical 
breast examination, there was a large firm, non-
tender mass in upper outer quadrant of the left 
breast and palpable ipsilateral axillary lymph nodes.
On mammogram, the left breast showed two 
adjacently placed circumscribed high-density 
masses in the upper outer quadrant, in the anterior 
Table 1: Criteria for primary breast lymphoma as 
per Wiseman and Liao.[5]
1. The availability of adequate pathology material
2.  Both mammary tissue and lymphomatous infiltrate are 
present
3.  No widespread disease or preceding extramammary 
lymphoma
4.  Ipsilateral axillary node involvement is considered 
acceptable
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breast. There were no suspicious calcifications, 
but enlarged ipsilateral axillary lymph nodes were 
seen [Figure  1.1a and b]. Her breast ultrasound 
demonstrated a heterogeneous hypoechoic mass 
in the upper outer quadrant corresponding to 
mammogram findings [Figure 1.2a] and a similar-
appearing mass at distance of 6  mm from the 
aforementioned mass [Figure 1.2b]. Her left axilla 
showed few enlarged lymph nodes with partially 
effaced fatty hilum [Figure  1.2c]. Ultrasound-
guided biopsy was performed and it confirmed the 
diagnosis of diffuse large B-cell lymphoma (DLBCL). 
Ultrasound-guided fine-needle aspiration cytology 
for the left axilla showed reactive lymph node. 
A  bone marrow biopsy was also performed that 
was negative for disease involvement. Her PET/CT 
scan revealed increased metabolic activity in both 
masses in the left breast and a standardised uptake 
value of 10.1 [Figure 1.3a and b]. Furthermore, there 
was increased metabolic activity in ipsilateral axillary 
and mediastinal lymph nodes with no metabolic 
activity elsewhere to suggest metastatic disease. 
The presence of mediastinal hypermetabolic activity 
was in favour of SBL.
She received 6  cycles of chemotherapy with 
rituximab, cyclophosphamide, adriamycin, 
vincristine and prednisone (R-CHOP) with central 
nervous system (CNS) prophylaxis, consisting of 
2  cycles of high-dose intrathecal methotrexate 
(MTX) as per MDT discussion. On a follow-up 
CT scan, there was an interval partial treatment 
response according to RECIST criteria.[6]
Case 2
A 34-year-old woman presented with  the 
left breast lump for 4  months and headache. 
There was no history of fever, night sweats or 
chills. On local breast examination, there were 
palpable masses in both breasts with no axillary 
lymphadenopathy.
Ultrasound of breast was performed. The left breast 
demonstrated a circumscribed hypoechoic mass 
corresponding to palpable site, extending in all 
Figure  1.1: (a and b) Mediolateral oblique and 
craniocaudal views of the left breast show two adjacently 
placed high-density masses with circumscribed 
margins in upper outer quadrant in anterior breast. No 
microcalcifications
ba
Figure 1.2: (a and b) Left breast ultrasound shows two adjacently placed masses in the left breast 2 and 3 o’clock, 
measuring 38 mm × 24 mm and 17 mm × 16 mm, respectively, with interlesional distance of 6 mm and demonstrating 
heterogeneous echotexture that gives ‘pseudocystic’ appearance. (c) Enlarged left axillary lymph nodes with partially 
effaced fatty hila, measuring 4 mm and 8 mm, respectively
a b c
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breast quadrants. In addition, a couple of satellite 
masses were found [Figure 2.1a and b]. No enlarged 
axillary nodes were present. Ultrasound of the right 
breast revealed an indistinct, hypoechoic mass in 
the central right breast. There was no evidence of 
increased vascularity on the Doppler ultrasound 
interrogation of the mass. However, few satellite 
masses [Figure 2.1c and d] and enlarged ipsilateral 
axillary lymph nodes were appreciated. Ultrasound-
guided biopsy was performed for the right breast 
retroareolar main mass and satellite mass at 6 o’clock 
and left breast main mass and largest satellite mass. 
The histopathology of biopsy samples confirmed the 
diagnosis of bilateral breast DLBCL. Subsequently, 
the contrast-enhanced CT scan showed a large 
enhancing mass with central low density in both 
breasts along with enlarged enhancing axillary 
nodes [Figure 2.2]. There was no evidence of visceral 
or nodal metastasis above or below diaphragm; 
therefore, this case was diagnosed as PBL.
MDT decision was to start chemotherapy with 
6  cycles of R-CHOP and 2  cycles of high-dose 
intrathecal MTX for CNS prophylaxis, followed by 
radiation therapy (XRT) to breasts. When she was 
undergoing her 1st  cycle of chemotherapy, she 
had sudden cardiac arrest. Multiple resuscitation 
attempts were made and she was shifted to 
intensive care unit (ICU) for further management. 
The patient experienced ischaemic brain injury 
Figure  1.3: (a and b) Fused positron emission 
tomography/computed tomography image is showing 
increased fluorodeoxyglucose uptake in the mass in the 
left breast with maximum standardised uptake value of 
10.1 along with uptake in ipsilateral axillary and right 
paratracheal lymph nodes
ba
Figure 2.1: (a) Ultrasound of the left breast is showing a large heterogeneous hypoechoic retroareolar mass, measuring 
7.3 cm × 4.8 cm. (b) Couple of rounds to oval hypoechoic satellite nodules (white arrows). (c) Ultrasound of the right 
breast is showing poorly circumscribed hypoechoic mass at 3 o’clock with retroareolar extension, measuring 3.6 cm 
× 2.5 cm. (d) Hypoechoic satellite lesions (yellow arrows)
a b
dc
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and died after prolonged ICU admission of 
approximately 75 days.
Case 3
A 61-year-old woman presented with the left 
breast lump for 6 months. There was a history of 
high-grade fever associated with rigors, chills, 
body aches and generalised weakness for 1 month. 
She had multiple comorbid conditions; including 
uncontrolled diabetes mellitus (Type II) and chronic 
kidney disease, stage 4.
Mammogram demonstrated a high-density mass 
with indistinct margins in the left breast which 
was present on the upper outer quadrant and 
upper central aspect, extending into the axillary 
tail [Figure 3.1a and b]. There were no suspicious 
grouped calcifications; however, benign linear 
calcifications were noted in the left breast. The 
ipsilateral axillary nodes were enlarged. The 
mammogram findings were confirmed on breast 
ultrasound, which showed an indistinct hypoechoic 
mass, extending from 12 o’clock to 2 o’clock as 
well as into the axillary tail [Figure  3.2a and b]. 
There were multiple enlarged ipsilateral axillary 
lymph nodes identified with loss of fatty hila. 
Ultrasound-guided biopsies were performed for 
the left breast mass and left axillary lymph node. 
The histopathology examination revealed DLBCL 
and reactive lymphoid hyperplasia, respectively.
CT neck to pelvis revealed more aggressive 
disease. There was a huge paramediastinal soft 
tissue mass in the right haemithorax which was 
invading the adjacent upper and middle lobes 
of the right lung. Mediastinal and pericardial 
invasion was present with superior vena cava 
compression and associated pleural effusion. 
Osseous involvement of the right 4th  rib was 
also demonstrated. The left breast mass was 
irregular and it was involving the overlying skin 
and extending into axilla and pectoralis major 
muscles. In addition, there was splenomegaly 
[Figure  3.3]. Based on the widespread disease 
in baseline CT, she was diagnosed as a patient 
of SBL.
Considering multiple comorbid conditions, MDT 
recommendation was to initiate palliative care, as she 
was unlikely to tolerate chemotherapy-associated 
toxicity. This patient was then lost to follow-up.
Case 4
A 32-year-old female presented with the left 
breast lump for 5  weeks. There was no history 
of fever, night sweats or chills. She underwent a 
biopsy of this mass and histopathology result was 
suggestive of DLBCL. Her CT chest, abdomen and 
pelvis showed a large left breast mass, occupying 
the lateral quadrants and enlarged left axillary, 
external iliac and pelvic sidewall lymph nodes 
[Figure 4.1a]. Furthermore, the CT was significant 
for a soft tissue mass in the left ischiorectal fossa, 
Figure 2.2: Axial computed tomography image of chest 
in soft tissue window shows heterogeneously enhancing 
circumscribed masses with indistinct margins in both 
breasts parenchyma with surrounding fat stranding
Figure  3.1: (a and b) Mammogram mediolateral 
oblique (a) and craniocaudal views (b) demonstrate a 
high-density mass with indistinct margins (*) in the left 
breast, upper outer quadrant and upper central aspect, 
extending into the axillary tail
a b
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which was concerning for disease involvement 
[Figure 4.1b]. Subsequently, she underwent a 
CT-guided biopsy of ischiorectal fossa mass and 
it showed the same histopathology, thereby, 
confirming the diagnosis of SBL.
M D T  r e c o m m e n d a t i o n s  w e r e  t o  s t a r t 
chemotherapy with 6  cycles of R-CHOP with 
2  cycles of high-dose intrathecal MTX for CNS 
prophylaxis and consolidative XRT to breast 
due to initial bulky disease. A follow-up CT scan 
was done after 3 cycles of chemotherapy which 
showed minimal hypodense linear soft tissue in 
the upper outer quadrant of the left breast and 
complete resolution of previously documented 
pelvic lymphadenopathy and left ischiorectal 
fossa mass. Four months after completion of her 
chemotherapy, the patient underwent PET/CT. 
Based on RECIST criteria, the patient showed a 
good treatment response with interval resolution 
of the left breast soft tissue mass along with 
metabolically insignificant residual soft tissue 
thickening [Figure 4.2]. The patient then received 
XRT of the left breast (200 centigray in 18 fractions) 
as per initial MDT instructions.
Discussion
Haematological malignancies are rare in breast. 
Nonetheless, lymphoma is the most common 
haematological malignancy to affect the breast.[1,3] 
The clinical presentation of BL is non-specific and 
may consist of a solitary or multiple unilateral or 
bilateral painless palpable breast masses, nipple 
or skin retraction and nipple discharge. On the 
contrary, the usual clinical symptoms seen with 
lymphomas such as fever, weight loss and night 
sweats, are very rare in PBL. The most common 
histologic type in BL is DLBCL. Other types, such as 
follicular lymphoma, mucosa-associated lymphoid 
tissue lymphoma or Burkett lymphoma are found in 
minority of cases.[7,8] The differential diagnosis of BL 
includes phyllodes tumour, atypical fibroadenoma, 
breast hamartoma, primary epithelial carcinoma 
and metastasis.[7]
Figure  3.3: Contrast-enhanced axial computed 
tomography image of thorax in soft tissue window 
shows aggressive disseminated disease. Large 
right paramediastinal locally infiltrative soft tissue 
heterogeneously enhancing mass is encasing and 
compressing the superior vena cava (white star). Left 
pleural based soft tissue nodule and right pleural effusion 
(orange arrows). Left breast deep infiltrative mass (white 
star) along with enlarged enhancing axillary lymph node 
(black star)
Figure  3.2: (a and b): Gray scale ultrasound demonstrates an irregular, solid mass with indistinct margins and 
heterogeneous echo pattern, measuring 45 mm × 18 mm (white star). It is associated with overlying skin infiltration 
and thickening
ba
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PBL has female predominance with  most 
commonly unilateral presentation. Bilateral 
involvement occurs in 1%–14% of cases.[9] It has 
been suggested that mammogram and ultrasound 
breast are required to evaluate breast mass and 
axillary lymph nodes.[4] Typically, on mammogram, 
PBL presents as an oval-shaped solitary mass 
with irregular or indistinct margins, preserved 
parenchymal architectural pattern without 
microcalcifications or spiculated margins.[10] 
It may present with diffuse increase in breast 
density. Appearance of axillary lymphadenopathy 
is rare. The SBL has variable imaging features 
on mammogram and ultrasound; however, 
multiplicity, extramammary extension and nodal 
involvement are favourable findings.[4] In a case 
series by Liberman et al. of 32  cases of non-
Hodgkin lymphoma in 29 women (66% classified 
as PBL), the most common mammographic 
finding was a solitary mass without calcifications 
(69%). Other findings consisted of multiple 
masses (9%) and diffuse increased opacity 
with skin thickening (9%). Interestingly, no 
mammographic abnormality was reported in 13% 
of the cases.[11] In another retrospective review of 
36 patients with BL (22 primary and 14 secondary) 
by Surov, no significant differences were noted 
on mammography and sonography between 
primary and SBL.[4] Similarly, mammographic 
findings in our cases were increased density 
masses, with well-circumscribed margins in one 
patient, while indistinct margins in the other 
case. Typical features which are frequently seen 
in invasive epithelial tumours such as spiculated 
margins or suspicious microcalcifications were 
not present.
As  in  mammography ,  u l t rasound lacks 
characteristic features. Ultrasound features 
of BL range from hypoechoic or isoechoic 
echotexture to diffuse infiltrative appearance 
with distinct or indistinct margins. Increased 
echogenicity, mixed hypo- and isoechoic pattern 
or pseudocystic appearance have also been 
described in literature.[4,6,11,12] Posterior acoustic 
enhancement can be present with an echogenic 
rim or onion peel-like rim surrounding the 
mass.[3] Lymphomas are usually hyper-vascular 
on Doppler ultrasound. Our cases demonstrated 
comparable findings as mentioned in literature. 
Two of the patients showed hypoechoic masses 
with circumscribed margins in one patient and 
indistinct margins in other case. Indistinct diffuse 
infiltrative pattern was also observed in a case.
CT study of chest, abdomen and pelvis can 
be useful for the evaluation of the local extent, 
invasion of chest wall, extramammary spread 
of disease and nodal involvement in the thorax 
or below the diaphragm. In the present case 
series, three patients underwent CT scan. The BL 
masses appeared as a mass with circumscribed 
Figure  4.2: Fused positron emission tomography/
computed tomography shows interval resolution of the 
left breast soft tissue mass with metabolically insignificant 
residual soft tissue thickening (red arrow)
Figure  4.1: (a) Contrast-enhanced axial computed 
tomography (CT) image of the thorax shows large 
left breast mass, measuring 10.7  cm × 10  cm (red*), 
occupying the lateral quadrants and enlarged left axillary 
lymph node, measuring 2 cm in long axis. (b) Contrast-
enhanced axial CT image of the pelvis shows soft tissue 
mass seen in the left ischiorectal fossa, measuring 
3.3 cm × 2.8 cm (blue arrow)
ba
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or irregular margins, with moderate or increased 
enhancement. This is similar to that reported 
previously.[4]
CT and PET/CT detect extramammary sites of 
disease involvement and aid in classification of BL 
(PBL or SBL). PET/CT scan performed as baseline 
study in one case showed hypermetabolic 
activity in the breast mass and mediastinal 
and axillary lymph nodes and thus detecting 
metastatic involvement. PET/CT performed as 
follow-up imaging after chemotherapy showed 
the treatment response in the form of decrease 
in tumour size and metabolic activity. These 
findings are similar to those described by Yang 
et al.[3] It has an acceptable role in staging, 
evaluation of treatment response and detection 
of recurrence on follow-up.[7,8] None of our 
participants underwent magnetic resonance 
imaging (MRI) of breast(s). There are handful 
of studies that have described MRI features of 
BL.[4,9] BL appears as an iso to hypointense mass 
on T1-weighted images and heterogeneously 
hyperintense on T2-weighted images, with 
marked early heterogeneous enhancement 
after gadolinium administration. Kinetics curves 
demonstrate a rapid early enhancement and 
plateau (Type II) or a slow washout in the delayed 
phase (Type III) curve.[4,7]
A possible limitation of the present investigation 
is that this was a retrospective analysis. As 
such, it was not possible to have a uniform 
set of standardised imaging modalities of all 
participants. Nonetheless, in this investigation, 
we have presented a diverse set of imaging 
modalities and described their findings in great 
details. Another limitation is that this series 
only consists of four participants. BL is a rare 
disease and it was not possible to include more 
participants. Furthermore, this is a novel case 
series, as to best of our understanding, no similar 
investigation has yet been published regarding 
imaging features of BL in this region. Based on the 
findings from this study, further investigations can 
be carried out to identify and assess patients of BL.
The early diagnosis of the BL is extremely 
relevant. Non-specific clinical presentation 
and imaging features require clinical history 
review, multimodality imaging approach and 
histopathology for diagnosis and management. 
Nonetheless, the radiologists should include 
lymphoma in the differential diagnosis when 
there is the absence of microcalcifications or 
spiculated margins on mammography and 
sonography. PET/CT finds its role in staging as 
well as in follow-up.
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